-
EP2219452
European procedure
Extract from the Register of European Patents
EP About this file: EP2219452
| EP2219452 - METHODS OF TREATING SCLERODERMA [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.08.2016 Database last updated on 26.04.2025 | Most recent event Tooltip | 19.08.2016 | No opposition filed within time limit | published on 21.09.2016 [2016/38] | Applicant(s) | For all designated states MedImmune, LLC One MedImmune Way Gaithersburg, MD 20878 / US | [2010/34] | Inventor(s) | 01 /
COYLE, Anthony 1155 23rd Street Washington, DC 20037 / US | [2015/42] |
| Former [2010/34] | 01 /
COYLE, Anthony 1155 23rd Street Washington DC 20037 / US | Representative(s) | Winter, Christopher Spencer MedImmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | [2015/42] |
| Former [2011/44] | Winter, Christopher Spencer Medlmmune Limited Milstein Building Granta Park Cambridge CB21 6GH / GB | ||
| Former [2010/34] | Bates, Rosica Florence Medlmmune Ltd. Milstein Building Granta Park Cambridge CB21 6GH / GB | Application number, filing date | 08847680.9 | 05.11.2008 | [2010/34] | WO2008US82481 | Priority number, date | US20070996175P | 05.11.2007 Original published format: US 996175 P | US20080100454P | 26.09.2008 Original published format: US 100454 P | [2015/21] |
| Former [2010/37] | US20070996175P | 05.11.2007 | |
| US20080100454 | 26.09.2008 | ||
| Former [2010/34] | US20070996175P | 05.11.2007 | |
| US20080100545 | 26.09.2008 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009061818 | Date: | 14.05.2009 | Language: | EN | [2009/20] | Type: | A1 Application with search report | No.: | EP2219452 | Date: | 25.08.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.05.2009 takes the place of the publication of the European patent application. | [2010/34] | Type: | B1 Patent specification | No.: | EP2219452 | Date: | 14.10.2015 | Language: | EN | [2015/42] | Search report(s) | International search report - published on: | US | 14.05.2009 | (Supplementary) European search report - dispatched on: | EP | 02.04.2012 | Classification | IPC: | A01N43/54, A61K39/395, C07K16/24 | [2012/18] | CPC: |
C07K16/249 (EP,US);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/14 (EP);
A61P29/02 (EP);
A61P37/00 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
C07K16/2866 (EP,US);
A61K2039/505 (EP,US)
(-)
|
| Former IPC [2010/34] | A01N43/54 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2015/42] |
| Former [2010/34] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | VERFAHREN ZUR BEHANDLUNG VON SKLERODERM | [2010/34] | English: | METHODS OF TREATING SCLERODERMA | [2010/34] | French: | PROCÉDÉS DE TRAITEMENT DE LA SCLÉRODERMIE | [2010/34] | Entry into regional phase | 04.06.2010 | National basic fee paid | 04.06.2010 | Search fee paid | 04.06.2010 | Designation fee(s) paid | 04.06.2010 | Examination fee paid | Examination procedure | 04.06.2010 | Examination requested [2010/34] | 26.10.2012 | Amendment by applicant (claims and/or description) | 30.10.2013 | Despatch of a communication from the examining division (Time limit: M04) | 06.03.2014 | Reply to a communication from the examining division | 06.05.2015 | Communication of intention to grant the patent | 03.09.2015 | Fee for grant paid | 03.09.2015 | Fee for publishing/printing paid | 03.09.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 30.10.2013 | Opposition(s) | 15.07.2016 | No opposition filed within time limit [2016/38] | Fees paid | Renewal fee | 24.11.2010 | Renewal fee patent year 03 | 23.11.2011 | Renewal fee patent year 04 | 26.11.2012 | Renewal fee patent year 05 | 27.11.2013 | Renewal fee patent year 06 | 26.11.2014 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2016/27] |
| Former [2016/25] | LV | 14.10.2015 | Documents cited: | Search | [A]WO2005067963 (INTERMUNE INC [US], et al) [A] 1-12 * paragraph [0143] - paragraph [0144] *; | [A]WO2007002096 (GENENTECH INC [US], et al) [A] 1-12 * page 7 - page 8 * * page 21, line 4 *; | [A]US2007092890 (ABBAS ALEXANDER [US]) [A] 1-12 * paragraph [0008] *; | [IP] - MACDERMOTT EMMA JANE ET AL, "Activation of type I interferon pathway in patients with systemic sclerosis (SSc) is associated with diffuse disease, antibodies to Ro and absence of Caucasian race", ARTHRITIS & RHEUMATISM, & 71ST ANNUAL MEETING OF THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY; BOSTON, MA, USA; NOVEMBER 06 -11, 2007, (200712), vol. 56, no. 12, ISSN 0004-3591, page 4244, XP009157116 [IP] 1-12 * abstract * | International search | [Y]US6333032 (SKURKOVICH BORIS [US], et al); | [Y]US2003088884 (HSU SHEAU YU [US], et al); | [Y]US2004265305 (VAISHNAW AKSHAY K [US]); | [X]US2007092890 (ABBAS ALEXANDER [US]) | by applicant | US3773919 | US4444887 | WO8403105 | EP0119476 | US4485045 | US4544545 | WO8605807 | EP0239400 | US4716111 | WO8901036 | US4816567 | US4816397 | US4885166 | US4902618 | WO9002809 | WO9101074 | US5013556 | WO9109967 | WO9110737 | WO9201047 | US5122464 | WO9218619 | WO9222324 | EP0519596 | WO9311236 | US5223409 | US5225539 | WO9317105 | EP0592106 | US5403484 | US5413923 | WO9515982 | US5427908 | WO9520401 | US5516637 | US5530101 | US5545806 | US5565332 | US5569825 | WO9634096 | WO9633735 | US5571698 | US5580717 | US5585089 | WO9713844 | US5625126 | US5633425 | US5658727 | US5661016 | US5698426 | US5733743 | WO9816654 | US5750753 | WO9824893 | US5766886 | US5780225 | US5807715 | US5814318 | US5821047 | WO9846645 | WO9850433 | US5939598 | US5969108 | US6311415 | US6407213 | US6713609 | US2006020118 | US2006029601 | US7087726 | US2006198840 | US2007014724 | WO2008070137 | WO2008070135 | - VARGA; ABRAHAM, J. CLIN. INVEST., (2007), vol. 117, pages 557 - 567 | - THEOFILOPOULOS AN; BACCALA R; BEUTLER B; KONO DH., "Type I Interferons (?/?) in immunity and autoimmunity.", IMMUNOL REV., (200504), vol. 204, pages 9 - 26 | - UZE ET AL., CELL, (1990), vol. 60, page 225 | - NOVICK ET AL., CELL, (1994), vol. 77, page 391 | - STARK GR; KERR IM; WILLIAMS BR; SILVERMAN RH; SCHREIBER RD., ANNU REV BIOCHEM, (1998), vol. 67, pages 227 - 64 | - THEOFILOPOULOS AN; BACCALA R; BEUTLER B; KONO DH., "Type I Interferons (a/b) in immunity and autoimmunity.", IMMUNOL REV., (200504), vol. 204, pages 9 - 26 | - BELARDELLI F; GRESSER I., "The neglected role of type I interferon in the T-cell response: implications for its clinical use.", IMMUNOL TODAY, (1996), vol. 17, pages 369 - 72 | - BANCHEREAU J; PASCUAL V; PALUCKA AK., "Autoimmunity through cytokine-induced dendritic cell activiation", IMMUNITY, (200405), vol. 20, pages 539 - 550 | - TAKI S. CYTOKINE, GROWTH FACTOR REVIEWS, (2002), vol. 13, pages 379 - 391 | - MAILLIARD RB; SON YI; REDLINGER R; COATES PT; GIERMASZ A; MOREL PA; STORKUS WJ; KALINSKI P, J IMMUNOL., (20030901), vol. 171, no. 5, pages 2366 - 73 | - FURST ET AL., J. OF RHEUMATOLOGY, (2007), vol. 34, no. 5, pages 1194 - 1200 | - CZIRJAK ET AL., ANN RHEUM DIS., (20070118), vol. 66, no. 7, pages 966 - 9 | - BRENNAN ET AL., BR J RHEUMATOL., (1992), vol. 31, no. 7, pages 457 - 60 | - MERKEL ET AL., ARTHRITIS & RHEUMATISM, (2002), vol. 46, no. 9, pages 2410 - 2420 | - WOOLDRIDGE ET AL., BLOOD, (1997), vol. 89, no. 8, page 2994 2998 | - BRINKMAN ET AL., J. IMMUNOL. METHODS, (1995), vol. 182, pages 41 - 50 | - AMES ET AL., J. IMMUNOL. METHODS, (1995), vol. 184, pages 177 - 186 | - KETTLEBOROUGH ET AL., EUR. J. IMMUNOL., (1994), vol. 24, pages 952 - 958 | - PERSIC ET AL., GENE, (1997), vol. 187, pages 9 - 18 | - BURTON ET AL., ADVANCES IN IMMUNOLOGY, (1994), vol. 57, pages 191 - 280 | - MULLINAX ET AL., BIOTECHNIQUES, (1992), vol. 12, no. 6, pages 864 - 869 | - SAWAI ET AL., AJRI, (1995), vol. 34, pages 26 - 34 | - BETTER ET AL., SCIENCE, (1988), vol. 240, pages 1041 - 1043 | - MORRISON, SCIENCE, (1985), vol. 229, page 1202 | - OI ET AL., BIOTECHNIQUES, (1986), vol. 4, page 214 | - GILLIE ET AL., J. IMMUNOL. METHODS, (1989), vol. 125, pages 191 - 202 | - PADLAN, MOLECULAR IMMUNOLOGY, (1991), vol. 28, no. 4/5, pages 489 - 498 | - STUDNICKA ET AL., PROTEIN ENGINEERING, (1994), vol. 7, no. 6, pages 805 - 814 | - ROGUSKA ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 969 - 973 | - TAN ET AL., J. IMMUNOL., (2002), vol. 169, pages 1119 - 25 | - CALDAS ET AL., PROTEIN ENG, (2000), vol. 13, no. 5, pages 353 - 60 | - MOREA ET AL., METHODS, (2000), vol. 20, no. 3, pages 267 - 79 | - BACA ET AL., J. BIOL. CHEM., (1997), vol. 272, no. 16, pages 10678 - 84 | - ROGUSKA ET AL., PROTEIN ENG., (1996), vol. 9, no. 10, pages 895 - 904 | - COUTO ET AL., CANCER RES., (1995), vol. 55, no. 23, pages 5973S - 5977S | - COUTO ET AL., CANCER RES., (1995), vol. 55, no. 8, pages 1717 - 22 | - SANDHU J S, GENE, (1994), vol. 150, no. 2, pages 409 - 10 | - PEDERSEN ET AL., J. MOL. BIOL., (1994), vol. 235, no. 3, pages 959 - 73 | - RIECHMANN ET AL., NATURE, (1988), vol. 332, page 323 | - KUTMEJER ET AL., BIOTECHNIQUES, (1994), vol. 17, page 242 | - Remington's Pharmaceutical Sciences, MACK PUBLISHING CO. | - EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, page 3688 | - HWANG ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, page 4030 | - MARTIN ET AL., J. BIOL. CHEM., (1982), vol. 257, page 286 288 | - GABIZON ET AL., J. NATIONAL CANCER INST., (1989), page 1484 | US20080941004 | US20080696208 | US20050157494 | US20070909232 | US20070909117 | US20080034618 | US20080049970 |